Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vacancy: Postdoctoral Research Scientist – Statistics

Research Grade 7: £39,424 - £47,779 with a discretionary range to £53,483 p.a. (pro rata). This is inclusive of a pensionable Oxford University Weighting of £1,730 per year (pro rata).

Vacancy: Postdoctoral Research Scientist – Brain Tumour Biology

Research Grade 7: £39,424 - £47,779 with a discretionary range to £53,483 p.a. (pro rata). This is inclusive of a pensionable Oxford University Weighting of £1,730 per year (pro rata).

Professor Xin Lu and Professor Chi Van Dang join global Cancer Grand Challenges team taking on the cancer avoidance challenge

Team ATLAS, an interdisciplinary collaboration including two researchers from the Ludwig Institute for Cancer Research, has been awarded up to $25 million over approximately five years through Cancer Grand Challenges to investigate the biological basis of cancer avoidance.

Professor Xin Lu featured on EACR’s The Cancer Researcher podcast

Professor Xin Lu features on the EACR podcast The Cancer Researcher, discussing her research on p53, the ASPP family and cellular plasticity.

Vacancy: Senior Imaging Manager

Standard Grade 8: £49,119 - £58,265 with a discretionary range to £63,489 p.a. (pro rata). This is inclusive of a pensionable Oxford University Weighting of £1,730 per year (pro rata).

Vacancy: Postdoctoral Research Scientist – Non-canonical nucleotides in cancer

Research Grade 7: £39,424 - £47,779 with a discretionary range to £53,483 p.a. (pro rata). This is inclusive of a pensionable Oxford University Weighting of £1,730 per year (pro rata).

Registration open for Ludwig Conference on Alternative Nucleic Acid Conformations in Health and Disease

The Oxford branch of the Ludwig Institute for Cancer Research welcomes registration and abstract submission for an upcoming international conference

Melanoma cells switch survival strategies under stress

Ludwig study reveals how melanoma cells reprogramme themselves to survive harsh conditions

Professor Xin Lu and Professor Yang Shi elected as Foreign Members of China’s Top Scientific Academies

Two Oxford Ludwig Professors have been recognised for their globally important work in advancing cancer research

Professor Richard White awarded prestigious Academy of Medical Sciences Professorship

Richard White, Professor of Genetics at Ludwig Oxford, has been named an Academy of Medical Sciences Professor

Ludwig researchers awarded grant to uncover how food-derived DNA changes may drive cancer risk

Ludwig scientists have been awarded a four-year grant from the World Cancer Research Fund International to investigate whether modified DNA molecules in food could contribute to mutations that drive bowel cancer.

Ludwig Oxford welcomes Dr Manav Pathania

Ludwig Oxford is delighted to welcome Dr Manav Pathania as an Assistant Member of the Ludwig Institute for Cancer Research, Oxford Branch.

Ludwig researchers develop first map of human RNA modification enzymes in landmark study

Findings published in Nature Cell Biology reveal how pseudouridine-modifying enzymes shape RNA biology.

From mutation to malignancy: mapping early events in kidney cancer

A new study from the Ratcliffe group examines how distinct HIFα isoforms shape the way VHL mutations lead to kidney cancer.

Richard White honoured with Teaching Excellence Award

Richard White recognised in the 2025 Medical Sciences Division Teaching Excellence Awards

Ludwig Oxford Director shortlisted for prestigious global research initiative, Cancer Grand Challenges

With awards of up to £20m, Cancer Grand Challenges teams are empowered to rise above the traditional boundaries of geography and discipline to make the progress against cancer we urgently need.

Impaired liver clearance drives accumulation of circulating cell-free DNA in sepsis

Study mapping cell-free DNA reveals new insights into organ dysfunction and infection in sepsis.

Discover the science behind the scenes at the Old Road Campus Research Building

The ORCRB will open to the public on 13th September as part of Oxford Open Doors.

Richard Owen takes on Oxford to Paris cycle ride for OOSO

Ludwig Oxford’s Richard Owen will participate in a three-day cycle ride from Oxford to Paris to raise funds for a new OOSO Fellowship.

Pressure flips the switch on cancer cells

A new study published in Nature reveals that the mechanical environment surrounding a tumour can cause cancer cells to change their behaviour, triggering a switch from rapid growth to a more invasive, drug-resistant state.

Load More